LAU-7b is an oral compound. It is a form of the retinoid fenretinide. Retinoids are a group of compounds related to vitamin A. LAU-7b was studied for its potential to reduce the inflammatory response in the lungs of people with CF.

Status

A phase 2 study to test the safety and effectiveness of LAU-7b in people with CF was completed. 

Sponsor

This program is sponsored by Laurent Pharmaceuticals. It was conducted within the Therapeutics Development Network.